EditorialInternational Journal of Pharmaceutical InvestigationVol. 1 | Issue 2 | pp. 61Open access
Nanopharmaceutics
- 1*
- 1 International Journal of Pharmaceutical Investigation, Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi - 110 062, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Javed Ali
International Journal of Pharmaceutical Investigation, Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi - 110 062, INDIA.
Email: javedaali@yahoo.com; editor@jpionline.org
- DOI:
- 10.4103/2230-973X.82382
How to cite
Ali, J. Nanopharmaceutics. International Journal of Pharmaceutical Investigation, 1(2), 61. https://doi.org/10.4103/2230-973X.82382
Abstract
Nanotechnology is now a part of our everyday life with or without our knowledge. Then, why can pharmaceutics not conceive this technology for its betterment? Yes, the same has been done for many years in the past in pharmaceutics and now nanopharmaceutics can be considered as one of the subdivisions of pharmaceutics. Although the term “nanopharmaceutics” is not being started to be used widely, I feel that it would be more suitable when we discuss the application of nanotechnology to drug delivery systems. “Nanopharmaceutics” can be defined as the science that deals with the application of the principles of nanotechnology in pharmaceutics. These delivery systems, because of their size effect, are capable of altering the properties of a drug, including their bioavailability, biodistribution and pharmacokinetics. Nanosizing of the drug itself is also another well-accepted and established technique for altering its properties.
Subject
Article metadata
| Title | Nanopharmaceutics |
|---|---|
| Authors | Javed Ali |
| Affiliations | International Journal of Pharmaceutical Investigation, Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi - 110 062, INDIA. |
| Corresponding author | javedaali@yahoo.com; editor@jpionline.org |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 1, Issue 2 |
Also in this issue
- Mucoadhesion; A prerequisite or a constraint in nasal drug delivery?pp. 62–63
- Recent trends in vaccine delivery systems: A reviewpp. 64–74
- Developing micro-/nanoparticulate drug delivery systems using “design of experiments”pp. 75–87
- Preparation of poly(NIPAAm)-Pluronic F68 as a thermosensitive surfactant for a controlled drug releasepp. 88–92
- Effect of agar—gelatin compositions on the release of salbutamol tabletspp. 93–98